Radiosensitizing effect of oleanolic acid on tumor cells through the inhibition of GSH synthesis in vitro

Oncology Reports

Volumn 30, Issue 2, 2013, Pages 917-924

  Wang, Juan ^a   Yu, Maohu ^a   Xiao, Linlin ^a   Xu, Shiguo ^a   Yi, Qiyi ^a   Jin, Wensen ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Glutathione; Irradiation; Oleanolic acid; Radiosensitizing effect

Indexed keywords

ACETYLCYSTEINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE SYNTHASE; OLEANOLIC ACID;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; RAT;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; DIPEPTIDES; DNA DAMAGE; DOWN-REGULATION; GLIOMA; GLUTATHIONE; GLUTATHIONE SYNTHASE; HUMANS; LUNG NEOPLASMS; OLEANOLIC ACID; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RATS;

EID: 84879638221     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2510     Document Type: Article

References (54)

1. Shah C, Grills IS, Kestin LL, McGrath S, Ye H, Martin SK and Yan D: Intrafraction variation of mean tumor position during image-guided hypofractionated stereotactic body radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 82: 1636-1641, 2012.
2. Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K and Pajonk F: Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res 12: R13, 2010.
3. Jamal M, Rath BH, Williams ES, Camphausen K and Tofilon PJ: Microenvironmental regulation of glioblastoma radioresponse. Clin Cancer Res 16: 6049-6059, 2010.
4. Ayouaz A, Raynaud C, Heride C, Revaud D and Sabatier L: Telomeres: hallmarks of radiosensitivity. Biochimie 90: 60-72, 2008. (Pubitemid 350216220)
5. Dumont F, Altmeyer A and Bischoff P: Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches. Expert Opin Ther Pat 19: 775-799, 2009.
6. Bondza-Kibangou P, Millot C, El Khoury V and Millot JM: Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells. Oncol Rep 18: 1513-1519, 2007.
7. Pani G, Galeotti T and Chiarugi P: Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29: 351-378, 2010.
8. Forkink M, Smeitink JA, Brock R, Willems PH and Koopman WJ: Detection and manipulation of mitochondrial reactive oxygen species in mammalian cells. Biochim Biophys Acta 1797: 1034-1044, 2010.
9. Forman HJ, Zhang H and Rinna A: Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 30: 1-12, 2009.
10. Circu ML and Aw TY: Glutathione and apoptosis. Free Radic Res 42: 689-706, 2008.
11. Wu G, Fang YZ, Yang S, Lupton JR and Turner ND: Glutathione metabolism and its implications for health. J Nutr 134: 489-492, 2004. (Pubitemid 38298485)
12. Botta D, White CC, Vliet-Gregg P, et al: Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice. Drug Metab Rev 40: 465-477, 2008. (Pubitemid 352019964)
13. Zhang W, Trachootham D, Liu J, et al: Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 14: 276-286, 2012.
14. Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ and Jordan VC: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. Breast Cancer Res 10: R104, 2008.
15. Ogunrinu TA and Sontheimer H. Hypoxia increases the dependence of glioma cells on glutathione. J Biol Chem 285: 37716-37724, 2010.
16. Ruiz-Gómez MJ, Souviron A, Martínez-Morillo M and Gil L: P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine. J Physiol Biochem 56: 307-312, 2000. (Pubitemid 32216811)
17. Inci E, Civelek S, Seven A, Inci F, Korkut N and Burçax G: Laryngeal cancer: in relation to oxidative stress. Tohoku J Exp Med 200: 17-23, 2003. (Pubitemid 36926788)
18. Honda T, Coppola S, Ghibelli L, et al: GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells. Cancer Gene Ther 11: 249-255, 2004. (Pubitemid 41184343)
19. Simons AL, Parsons AD, Foster KA, Orcutt KP, Fath MA and Spitz DR: Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells. J Oncol 2009: 519563, 2009.
20. Boivin A, Hanot M, Malesys C, Maalouf M, Rousson R, Rodriguez-Lafrasse C and Ardail D: Transient alteration of cellular redox buffering before irradiation triggers apoptosis in head and neck carcinoma stem and non-stem cells. PLoS One 6: e14558, 2011.
21. Pollier J and Goossens A: Oleanolic acid. Phytochemistry 77: 10-15, 2012.
22. Yang EJ, Lee W, Ku SK, Song KS and Bae JS: Anti-inflammatory activities of oleanolic acid on HMGB1 activated HUVECs. Food Chem Toxicol 50: 1288-1294, 2012.
23. Reisman SA, Aleksunes LM and Klaassen CD: Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem Pharmacol 77: 1273-1282, 2009.
24. Yim TK, Wu WK, Pak WF and Ko KM: Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother Res 15: 589-592, 2001. (Pubitemid 33021864)
25. Hsu HY, Yang JJ and Lin CC: Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 111: 7-13, 1997.
26. Fujiwara Y, Komohara Y, Kudo R, Tsurushima K, Ohnishi K, Ikeda T and Takeya M: Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncol Rep 26: 1533-1537, 2011.
27. Wei J, Liu H, Liu M, et al: Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells. Oncol Rep 28: 1339-1345, 2012.
28. Bishayee A, Ahmed S, Brankov N and Perloff M: Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front Biosci 16: 980-996, 2011.
29. Yamai H, Sawada N, Yoshida T, et al: Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer 125: 952-960, 2009.
30. White CC, Viernes H, Krejsa CM, Botta D and Kavanagh TJ: Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem 318: 175-180, 2003. (Pubitemid 36694107)
31. Frosina G: DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res 7: 989-999, 2009.
32. Chang JY and Cox JD: Improving radiation conformality in the treatment of non-small cell lung cancer. Semin Radiat Oncol 20: 171-177, 2010.
33. Kim M, Lee J, Ha B, Lee R, Lee KJ and Suh HS: Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer. Radiat Oncol J 29: 181-190, 2011.
34. Zerp SF, Stoter R, Kuipers G, et al: AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis. Radiat Oncol 4: 47, 2009.
35. Rao SK, Rao PS and Rao BN: Preliminary investigation of the radiosensitizing activity of guduchi (Tinospora cordifolia) in tumor-bearing mice. Phytother Res 22: 1482-1489, 2008. (Pubitemid 352789618)
36. Dai Y, DeSano JT, Meng Y, Ji Q, Ljungman M, Lawrence TS and Xu L: Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer. Int J Radiat Oncol Biol Phys 74: 1217-1225, 2009.
37. Tsai SJ and Yin MC: Anti-oxidative, anti-glycative and anti-apoptotic effects of oleanolic acid in brain of mice treated by D-galactose. Eur J Pharmacol 689: 81-88, 2012.
38. Koh SJ, Tak JK, Kim ST, Nam WS, Kim SY, Park KM and Park JW: Sensitization of ionizing radiation-induced apoptosis by ursolic acid. Free Radic Res 46: 339-345, 2012.
39. Eder-Czembirek C, Erovic BM, Czembirek C, Brunner M, Selzer E, Pötter R and Thurnher D: Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 186: 143-148, 2010.
40. Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B and Kodym R: Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 114: 935-940, 2000. (Pubitemid 30252714)
41. Yang JC, Lu MC, Lee CL, Chen GY, Lin YY, Chang FR and Wu YC: Selective targeting of breast cancer cells through ROS-mediated mechanisms potentiates the lethality of paclitaxel by a novel diterpene, gelomulide K. Free Radic Biol Med 51: 641-657, 2011.
42. Karthikeyan S, Kanimozhi G, Prasad NR and Mahalakshmi R: Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicol In Vitro 25: 1366-1375, 2011.
43. Benassi B, Zupi G and Biroccio A: Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells. Mol Pharmacol 72: 1015-1023, 2007. (Pubitemid 47481424)
44. Oliveira NG, Castro M, Rodrigues AS, et al: Wortmannin enhances the induction of micronuclei by low and high LET radiation. Mutagenesis 18: 37-44, 2003. (Pubitemid 36113606)
45. Sedelnikova OA, Nakamura A, Kovalchuk O, et al: DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Res 67: 4295-4302, 2007. (Pubitemid 46815077)
46. Kashino G, Prise KM, Suzuki K, et al: Effective suppression of bystander effects by DMSO treatment of irradiated CHO cells. J Radiat Res 48: 327-333, 2007. (Pubitemid 47105604)
47. Shao C, Furusawa Y, Kobayashi Y, Funayama T and Wada S: Bystander effect induced by counted high-LET particles in confluent human fibroblasts: a mechanistic study. FASEB J 17: 1422-1427, 2003. (Pubitemid 36935656)
48. Thierens H and Vral A: The micronucleus assay in radiation accidents. Ann Ist Super Sanita 45: 260-264, 2009.
49. McConnachie LA, Mohar I, Hudson FN, et al: Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci 99: 628-636, 2007. (Pubitemid 351753076)
50. Bai X, Qiu A, Guan J and Shi Z: Antioxidant and protective effect of an oleanolic acid-enriched extract of A. deliciosa root on carbon tetrachloride induced rat liver injury. Asia Pac J Clin Nutr 16 (Suppl 1): 169-173, 2007. (Pubitemid 46524594)
51. Abdel-Zaher AO, Abdel-Rahman MM, Hafez MM and Omran FM: Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage. Toxicology 234: 124-134, 2007. (Pubitemid 46517830)
52. Petronelli A, Saulle E, Pasquini L, et al: High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-imidazolide. Cancer Lett 282: 214-228, 2009.
53. Ikeda T, Sporn M, Honda T, Gribble GW and Kufe D: The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance. Cancer Res 63: 5551-5558, 2003. (Pubitemid 37139877)
54. Haddad JJ, Olver RE and Land SC: Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 275: 21130-21139, 2000. (Pubitemid 30481806)